CCL21/CCR7 enhances the proliferation, migration, and invasion of human bladder cancer T24 cells.

CCL21/CCR7 enhances the proliferation, migration, and invasion of human bladder cancer T24 cells.
复制标题

DOI:
10.1371/journal.pone.0119506
复制
发表时间:
2015
期刊:
影响因子:
3.7
通讯作者:
Zu XB
Zu XB
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Mo M;Zhou M;Wang L;Qi L;Zhou K;Liu LF;Chen Z;Zu XB

文献摘要

参考文献

被引文献

相似文献

To investigate the effects of CCL21/CCR7 on the proliferation, migration, and invasion of T24 cells and the possible associated mechanisms: expression of MMP-2 and MMP-9, and regulation of BCL-2 and BAX proteins. T24 cells received corresponding treatments including vehicle control, antibody (20ng/mL CCR7 antibody and 50 ng/ml CCL21), and 50, 100, and 200 ng/ml CCL21. Proliferation was evaluated by MTT assay; cell migration and invasion were assayed using a transwell chamber. Cell apoptosis was induced by Adriamycin (ADM). The rate of cell apoptosis was examined by flow cytometry using annexin V-FITC/PI staining. Western-blot was used to analyze MMP-2 and MMP-9 and BCL-2 and BAX proteins. CCL21 promoted T24 cell proliferation in concentration-dependent manner with that 200 ng/mL induced the largest amount of proliferation. Significant differences of cell migration were found between CCL21treatment groups and the control group in both the migration and invasion studies (P < 0.001 for all). The expressions of MMP-2 and MMP-9 proteins were significantly increased after CCL21 treatment (p < 0.05 for all). Protein expression of Bcl-21 follows an ascending trend while the expression of Bax follows a descending trend as the concentration of CCL21 increases. No difference was found between the control group and antibody group for all assessments. CCL21/CCR7 promoted T24 cell proliferation and enhanced its migration and invasion via the increased expression of MMP-2 and MMP-9. CCL21/CCR7 had antiapoptotic activities on T24 cells via regulation of Bcl-2 and Bax proteins. CCL21/CCR7 may promote bladder cancer development and metastasis.
DOI: 10.4049/jimmunol.167.12.6724
发表时间: 2001-12-15
影响因子: 4.4
作者:
Ploix, C;Lo, D;Carson, MJ
通讯作者: Carson, MJ
DOI: 10.1038/sj.onc.1209149
发表时间: 2006-02-23
期刊: ONCOGENE
影响因子: 8
作者:
Itoh, M;Murata, T;Yoshida, K
通讯作者: Yoshida, K
DOI: 10.1038/35065016
发表时间: 2001-03-01
期刊: NATURE
影响因子: 64.8
作者:
Müller, A;Homey, B;Zlotnik, A
通讯作者: Zlotnik, A
DOI: 10.1159/000139126
发表时间: 2008-01-01
期刊: ONCOLOGY
影响因子: 3.5
作者:
Nakata, Bunzo;Fukunaga, Shinya;Hirakawa, Kosei
通讯作者: Hirakawa, Kosei